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Background: Intraluminal femoropopliteal stenting enables favorable dilation and good immediate results; however,
whether this contributes to long-term patency is unclear. We compared patency after femoropopliteal stenting for a long
occlusion using either an intraluminal or subintimal approach.
Methods: Between January 2004 and December 2011, 902 endovascular procedures using either an intraluminal approach
(651 procedures) or a subintimal approach (251 procedures) for long femoropopliteal occlusion were analyzed retro-
spectively. The outcomes of this study were periprocedural complication; primary, assisted-primary, and secondary
patency; and overall survival.
Results: The mean follow-up period of survivors was 296 16 months. Between the intraluminal and subintimal approach,
technical success (91% vs 90%; P[ .71) and periprocedural complications (11% vs 13%; P[ .34) were similar. However,
procedure time was signiﬁcantly longer for the intraluminal approach (126 6 63 minutes vs 98 6 49 minutes; P[ .003).
The improvement of ankle-brachial index was also similar. A quarter of cases started with the intraluminal approach were
switched to a subintimal approach. There was no signiﬁcant difference in primary, assisted-primary and secondary patency
at 3 years between the two groups (55% vs 53%; P [ .30; 65% vs 74%; P [ .11; and 80% vs 85%; P [ .37). The 3-year
overall survival also did not differ signiﬁcantly between groups (84% vs 86%; P [ .55). After adjusting for baseline
differences, the subintimal approach was found to be similar to the intraluminal approach for primary patency (hazard
ratio, 1.21; 95% conﬁdence interval, 0.94-1.56; adjusted P [ .14).
Conclusions: Initial result and 3-year patency was similar in both approaches. Given the longer procedure time and high
crossover rate, we suggest that a subintimal approach may be preferred in the treatment of long femoropopliteal
occlusions with stenting. (J Vasc Surg 2013;58:1547-55.)A subintimal approach for femoropopliteal occlusion
was ﬁrst suggested by Bolia et al in 1989.1 Bolia and Reekers
then described the original technique, in which recanaliza-
tion was performed with a 0.035-inch looped guidewire
and a supporting catheter at the occlusion site.2,3 Due to
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://dx.doi.org/10.1016/j.jvs.2013.05.107many patients with femoropopliteal occlusion. However,
re-entry often becomes difﬁcult when the wire passes the
distal true lumen after excessive reach beyond the subinti-
mal space. The lesion may become longer than the original
length, and serious complications such as vessel rupture may
develop due to overexpansion. In contrast, in an intralumi-
nal approach, the response to the balloon is favorable, but
the outcome depends on the experience of the surgeon,
and the approach requires more time and is more costly.4
In recent years, favorable patency rates have been
achieved for relatively long femoropopliteal lesions thanks
to development of stents.5-7 The use of endovascular therapy
(EVT) for femoropopliteal lesions has markedly increased,
and EVT has been aggressively used for more complicated
lesions.8 However, insufﬁcient dilation and recoil occur in
many cases with stent placement in the subintimal space
in the acute phase, especially in those with calciﬁed lesions.
In addition, stent placement using an intraluminal approach
enables sufﬁcient poststenotic dilation, leading to favorable
acute results, and this may contribute to patency.
Here, we report the results of a comparison of patency
at 3 years in patients who underwent stent placement for
a long femoropopliteal occlusion with a subintimal or intra-
luminal approach.1547
Fig 1. Participant ﬂow. IVUS, Intravascular ultrasound; US, ultrasound.
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Study population. The study was performed as
a multicenter retrospective analysis of a prospectively main-
tained database. Between January 2004 and December
2011, 3623 consecutive patients underwent EVT for de
novo femoropopliteal disease at hospitals involved in the
study. Of these cases, 2721 patients were excluded because
of procedure failure (152 patients), a stenotic or short
(<10 cm) occlusive lesion (2452 patients), treatment
with angioplasty alone (51 patients), or inadequate proce-
dural data (44 patients). Therefore, 902 patients who
underwent successful femoropopliteal stenting for a de
novo long (>10 cm) occlusive lesion were identiﬁed and
analyzed in this study (Fig 1).
Baseline clinical and lesion characteristics and proce-
dural data were collected from each hospital database.
The mean follow-up period for survivors was 29 6 16
months.Procedures and follow-up. All patients were medi-
cated with dual antiplatelet therapy (aspirin 100 mg/
day þ clopidogrel 75 mg/day, ticlopidine 100 mg twice
a day or cilostazol 100 mg twice a day) by the day before
EVT or earlier. Either ipsilateral or contralateral femoral
puncture was used. After insertion of a 6F sheath, an
intra-arterial bolus of 5000 IU of heparin was injected and
supplemented as required to maintain an active clotting
time >200 seconds. The intraluminal or subintimal routes
were chosen by each operator according to the institutional
strategy or lesion (patient) background.
In the subintimal approach, a 0.035-inch hydro-
philic guidewire (Radifocus; Terumo, Tokyo, Japan)
and a supporting 4F catheter (Grideach; Terumo) were
used to cross the totally occluded lesion. A 0.035-inch
hydrophilic guidewire was advanced distally using a loop
formed at the tip of the guidewire. The loop of the wire
and catheter were advanced through the subintimal plane
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an antegrade approach was unsuccessful, re-entry using
subintimal arterial ﬂossing with antegrade-retrograde inter-
vention was performed to achieve recanalization.9
In the intraluminal approach, a microcatheter was used
as a support for advancing a 0.018- or 0.014-inch guide-
wire to the lesion. We ﬁrst used a soft guidewire and
then gradually changed to a stiff type, depending on the
lesion. The procedure was performed such that the guide-
wire passed through the true lumen of the blood vessel as
much as possible, as conﬁrmed by body surface echography
and intravascular ultrasound (IVUS) as needed. In cases in
which it was difﬁcult to pass the guidewire through the true
lumen antegradely, the guidewire was advanced intralumi-
nally with support of a microcatheter from the distal true
lumen with a retrograde approach from the popliteal or
tibial artery. The wire was then passed through the occlu-
sion site using the rendezvous and kissing microcatheter
techniques in the true lumen.10,11 In cases in which contin-
uation of the intraluminal approach was difﬁcult secondary,
for example, to a high level of calciﬁcation, a decision to
switch to a subintimal approach (crossover) could be
made by the operator.
After passing the wire, predilatation was performed
with an appropriately sized angioplasty balloon before
stenting. Three types of nitinol stents were then implanted
to cover the whole lesion: Luminexx (Bard, Murray Hill,
NJ), S.M.A.R.T. (Cordis Johnson & Johnson, Miami,
Fla), and Zilver518 (Cook Medical, Bloomington, Ind).
The stent type was determined by the operator, and the
stent size was chosen to be 1 to 2 mm larger than the refer-
ence vessel diameter. After stent placement, postdilatation
was performed in all cases.
After the procedure, all patients were prescribed life-
long aspirin (100 mg/day) and prolonged (at least 1
month) clopidogrel 75 mg/day, ticlopidine 100 mg twice
a day, or cilostazol 100 mg twice a day was recommended.
The presence of stent fracture and the stented vessel were
monitored by X ray and duplex ultrasound respectively at
least every 6 months.
Study end points. The primary end point was primary
patency, and the secondary end points were periprocedural
complication, assisted-primary patency, secondary patency,
and overall survival.
Deﬁnitions. Primary patency was deﬁned as a treated
vessel without restenosis or repeat revascularization. As-
sisted primary patency was deﬁned as a patent treated vessel
that underwent repeat revascularization to improve
patency. Secondary patency was deﬁned as a target vessel
that subsequently became totally occluded and was re-
opened by repeat revascularization. Restenosis was deﬁned
as >2.5 times the peak systolic velocity ratio on duplex
ultrasound. An undetectable signal in stented segments in
duplex ultrasound was graded as complete occlusion. Peri-
procedural complications included major adverse events
(death, acute myocardial infarction, and stroke within 48
hours after the procedure), intestinal bleeding, distal
embolization, surgical repair, worsening renal function,blood transfusion, access site complication, fever or infec-
tion, or any other reason for prolongation of the hospital
stay. Worsening renal function was deﬁned as an increase
of serum creatinine by at least 0.3 mg/dL from baseline.
Stent fracture was deﬁned as clear interruption of stent
struts on X ray, with resulting kink or misalignment along
the axial length of the stent. Below-the-knee run-off was
assessed by angiography before or after the procedure.
Calciﬁed lesions were deﬁned as obvious densities noted
within the apparent vascular wall in the angiogram. Poor
runoff was deﬁned as one vessel or fewer vessels for below-
the-knee runoff. Limb salvage was deﬁned as freedom from
amputation above the ankle. Coronary artery disease was
deﬁned as stable angina with the evidence of coronary
stenosis documented by coronary catheterization or func-
tional or perfusion studies, history of percutaneous coro-
nary intervention or coronary artery bypass graft surgery, or
previous myocardial infarction. Cerebrovascular disease was
deﬁned as a hospital or neurologist report with diagnosis of
a transient ischemic attack or ischemic stroke. Heart failure
(HF) was judged to be present based on a previous diag-
nosis of HF, a history of hospitalization for HF, or current
treatment for HF. Diabetes was deﬁned as HbA1c >6.5%,
random plasma glucose >200 mg/dL, or current treat-
ment with oral hypoglycemic agents or insulin injection.
Hypertension was deﬁned as systolic blood pressure $140
mm Hg, diastolic blood pressure $90 mm Hg, or ongoing
therapy for hypertension.
Statistical analysis. Values are reported as the mean6
standard deviation. Continuous variables were examined by
unpaired t-test, and categorical variables were compared by
c2 test. Survival curves were estimated by the Kaplan-Meier
method and compared using a log-rank test. All analyses
were based on an intention-to-treat (ITT) principle.
However, to decrease crossover effects, an as-treated (AT)
analysis was also performed for the group of patients who
eventually underwent EVT by both intraluminal and sub-
intimal approaches. Hazard ratio (HR), 95% conﬁdence
interval (CI), and P value were calculated using models
adjusted for signiﬁcant baseline factors of age, gender,
previous smoker, chronic obstructive pulmonary disease
(COPD), lesion length, reference vessel diameter and stent
fracture. A probability value <.05 was considered to be
statistically signiﬁcant.
RESULTS
Baseline and procedural characteristics. The base-
line characteristics of the patients are listed in Table I.
The intraluminal group was older, with more females,
fewer previous smokers, and fewer individuals with COPD.
There was no other signiﬁcant difference in the back-
ground characteristics of the intraluminal and subintimal
groups. Lesion background characteristics are shown in
Table II. The subintimal group had longer lesions and a
larger vascular diameter, and thus the length and diameter
of the stent placed for the lesions were signiﬁcantly larger
than those in the intraluminal group. There was no sig-
niﬁcant difference in pre- and postprocedural ankle-brachial
Table I. Patient characteristics
Patient characteristics Intraluminal (n ¼ 530 patients), No. (%) Subintimal (n ¼ 189 patients), No. (%) P value
Age, years 74 6 9 72 6 9 .04
>80 years 146 (28) 41 (22) .12
Female gender 164 (31) 44 (23) .046
Body mass index, kg/m2 6 SD 22 6 3 22 6 3 .52
<18 kg/m2 59 (12) 227 (14) .32
>30 kg/m2 7 (1) 2 (1) .75
Ambulatory 451 (85) 154 (81) .24
Hypertension 464 (88) 159 (84) .24
Hyperlipidemia 267 (50) 98 (52) .73
Diabetes 308 (58) 110 (58) .98
Hemodialysis 88 (17) 25 (13) .27
Current smoker 148 (28) 54 (29) .87
Previous smoker 234 (44) 108 (57) .002
Cerebrovascular disease 132 (25) 43 (23) .55
Coronary artery disease 261 (49) 91 (48) .80
COPD 32 (6) 3 (1.6) .01
Atrial ﬁbrillation 37 (7) 16 (8) .50
HF 57 (11) 19 (10) .79
CLI 166 (31) 58 (31) .87
Medication
Aspirin 472 (89) 160 (85) .11
Thienopyridines 271 (51) 93 (49) .65
Cilostazol 287 (54) 114 (60) .14
Statin 203 (38) 69 (37) .66
Warfarin 66 (12) 26 (14) .65
Beta-blocker 142 (27) 43 (23) .28
Calcium-antagonist 276 (53) 97 (51) .75
CLI, Critical limb ischemia; COPD, chronic obstructive pulmonary disease; HF, heart failure; SD, standard deviation.
Continuous data are shown as mean 6 standard deviation and categoric data as number (%).
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more common in the subintimal group, probably due to
the use of longer stents or more severe calciﬁcation. There
was no other signiﬁcant difference between the lesions in
the two groups.
Procedure and complication. Technical success
(including 91 cases with procedural failure) was similar
between the intraluminal approach and subintimal
approach (91% vs 90%; P ¼ .71). The procedure time
was signiﬁcantly longer (126 6 63 minutes vs 98 6 49
minutes; P ¼ .003) and the use of body surface echography
(18% vs 8%; P < .0001) and IVUS (37% vs 16%; P <
.0001) were signiﬁcantly higher in the intraluminal group
(Fig 1). The number of subjects who required additional
distal puncture in a bidirectional approach (intraluminal vs
subintimal, 39% vs 37%; P ¼ .70) and the amount of
contrast media used (124 6 65 mL vs 122 6 58 mL; P ¼
.67) were similar in the two groups. Of the 651 procedures
initially performed with an intraluminal approach, 163
(25%) were switched to a subintimal approach. There was
no vessel rupture in either group, and distal emboli rates
were also similar. The ITT and AT analyses showed
a similar incidence of periprocedural complications in the
two groups (11% vs 13%; P ¼ .34; Table III).
Patency. There was no signiﬁcant difference in the
3-year primary patency between the intraluminal and sub-
intimal groups in the ITT (55% vs 53%; log-rank, P ¼ .30;
Fig 2,A) or AT (55% vs 54%; P¼ .83; Fig 2, B) analyses. The
3-year assisted-primary patency was also similar in the twogroups in the ITT analysis (65% vs 74%;P¼ .11; Fig 3,A) but
was signiﬁcantly lower in the intraluminal group in the AT
analysis (65% vs 70%; P ¼ .047; Fig 3, B). The 3-year
secondary patency was similar in the ITT (80% vs 85%; P ¼
.37; Fig 3, C) and AT (79% vs 84%; P ¼ .14; Fig 3, D)
analyses. The 3-year overall survival also did not differ
signiﬁcantly between the two groups in the ITT (84% vs 86%;
P ¼ .55; Fig 3, E) and AT (84% vs 84%; P ¼ .84; Fig 3, F)
analyses. During follow-up period, 103 patients died. The
cause of death was cardiac in 37 patients (36%), vascular in 15
patients (15%), noncardiovascular in 41 patients (40%), and
unknown 10 patients (10%). Regarding limb salvage rate, the
3-year overall limb salvage rate was signiﬁcant higher in the
subintimal group in the ITT analysis (96% vs 99%; P ¼ .03;
Fig 3, G). There is, however, no signiﬁcant difference in the
AT (96% vs 98%;P¼ .32; Fig 3,H). For critical limb ischemia
(CLI) patients, there is no signiﬁcant difference in the 3-year
limb salvage rate by either analysis (ITT, 85% vs 96%; P¼ .07;
Fig 4, A) or AT (87% vs 90%; P ¼ .32; Fig 4, B). The 3-year
amputation-free survival in CLI patients did not differ
between the two groups in the ITT (69% vs 66%; P¼ .32) or
AT (69% vs 68%; P ¼ .48) analyses.
Lesion characteristics in patients with crossover from
an intraluminal to subintimal approach (163 of 651
patients) included a smaller vessel diameter (4.8 mm vs
5.4 mm; P < .0001) and more frequent calciﬁcation
(35% vs 26%; P ¼ .02) compared with those without cross-
over. The incidences of complications (9% vs 12%; P ¼ .28)
and restenosis (36% vs 35%; P ¼ .96) were similar in these
Table II. Lesion characteristics
Lesion characteristics Intraluminal (n ¼ 651 limbs) Subintimal (n ¼ 251 limbs) P value
Lesion length, mm 215 6 61 235 6 56 <.0001
Occlusion length, mm 151 6 43 164 6 40 <.0001
Reference vessel diameter, mm 5.2 6 0.9 5.4 6 0.8 .0007
Preprocedural % stenosis 100 100 .99
Postprocedural % stenosis 18 6 16 18 6 17 .85
TASC classiﬁcation A/B/C/D 0/0/193/458 0/0/59/192 .07
Calciﬁed lesiona 183 (28) 75 (30) .60
Poor runoff b 294 (45) 117 (47) .69
Total stent length, mm 231 6 73 252 6 65 <.0001
Stent diameter, mm 6.6 6 0.8 7.0 6 0.9 <.0001
Number of stents 2.6 6 0.8 2.7 6 0.7 .10
Final balloon diameter, mm 5.2 6 0.8 5.3 6 0.7 .10
Preprocedural ABI 0.55 6 0.20 0.55 6 0.21 .85
Claudicant 0.59 6 0.16 0.59 6 0.16 .65
CLI 0.46 6 0.26 0.42 6 0.27 .37
Postprocedural ABI 0.88 6 0.17 0.88 6 0.16 .98
Claudicant 0.90 6 0.17 0.90 6 0.15 .81
CLI 0.83 6 0.18 0.84 6 0.18 .82
Approach
Crossover 331 (51) 127 (51) .91
Ipsilateral antegrade 55 (8) 26 (10)
Ipsilateral retrograde 10 (2) 3 (1)
Bidirectional 253 (34) 94 (37)
Others 2 (0.4) 1 (0.3)
Use of stent
SMART 538 (83) 200 (80) .16
Luminexx 80 (12) 42 (17)
Zilver 33 (5) 9 (4)
Stent fracturec 29 (5) 27 (11) .0004
Procedure time, minutes 117 6 59 93 6 42 <.0001
Use of contrast media, mL 124 6 65 122 6 58 .67
ABI, Ankle-brachial index; CLI, critical limb ischemia.
Continuous data are shown as mean 6 standard deviation and categoric data as number (%).
aCalciﬁed lesion deﬁned as obvious densities noted within the apparent vascular wall in the angiogram.
bPoor runoff was deﬁned as one or no infrapopliteal vessel runoff.
cStent fracture was deﬁned as clear interruption of stent struts identiﬁed by X ray from more than two projections.
Table III. Complications
ITT AT
Intraluminal
(n ¼ 651),
No. (%)
Subintimal
(n ¼ 251),
No. (%) P value
Intraluminal
(n ¼ 489),
No. (%)
Subintimal
(n ¼ 413),
No. (%) P value
All complications 71 (11) 33 (13) .34 57 (12) 47 (11) .90
Death/myocardial infarction/
stroke
4 (0.6) 0 (0) .21 3 (0.6) 1 (0.2) .40
Intestinal bleeding 0 (0) 0 (0) .99 0 (0) 0 (0) .99
Distal emboli 9 (1) 4 (1) .81 8 (2) 5 (1) .59
Urgent surgical revascularization 10 (2) 2 (1) .39 9 (2) 3 (1) .15
Worsening renal functiona 3 (0.5) 1 (0.4) .90 3 (0.5) 1 (0.4) .40
Transfusion 27 (4) 11 (4) .87 23 (5) 15 (4) .42
Access site complication 34 (5) 11 (4) .60 27 (6) 18 (4) .42
Fever or infection 12 (2) 9 (4) .12 9 (2) 12 (3) .29
Others 10 (2) 5 (2) .63 8 (2) 7 (2) .95
AT, As-treated; ITT, intention-to-treat.
aWorsening renal function was regarded as more than 0.3 mg/dL of serum creatinine elevations from baseline.
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.0001) and the amount of contrast media (103 mL vs 136
mL; P < .0001) were reduced in cases with crossover to
a subintimal approach.In subgroup analysis, we evaluated the primary
patency in the ischemic severity (claudication and CLI)
and degrees of CLI (rest pain and gangrene). In claudicant
patients, there is no signiﬁcant difference in primary
A B
Fig 2. Primary patency after femoropopliteal stenting in patients who received intraluminal or subintimal approach.
A, Intention-to-treat (ITT) analysis. B, As-treated (AS) analysis.
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(61% vs 59% at 2-year; log-rank, P ¼ .19). Also, there is
no signiﬁcant difference in CLI patients in different
approaches (62% vs 65% at 2-year; log-rank, P ¼ .93).
Similarly, primary patency does not differ between claudi-
cant and CLI patients in both intraluminal (61% vs 62% at
2-year; log-rank, P ¼ .30) and subintimal approach (59%
vs 65% at 2-year; log-rank, P ¼ .82). Regarding the degree
of CLI, there is no signiﬁcant difference in patients with
rest pain between intraluminal and subintimal approach
(67% vs 55% at 2-year; log-rank, P ¼ .54). Also, there is
no signiﬁcant difference in patients with gangrene (56%
vs 69% at 2-year, log-rank, P ¼ .35). Primary patency
also does not differ between rest pain and gangrene in
both intraluminal (67% vs 56% at 2-year; log-rank, P ¼
.29) and subintimal approach (55% vs 69% at 2-year;
log-rank, P ¼ .63). The differences of approach (intralu-
minal or subintimal) for femoropopliteal occlusion largely
unaffected the primary patency in ischemic severity or the
degree of CLI. In addition, we examined the change of
ABI as a functional assessment. There was no signiﬁcant
difference between intraluminal and subintimal approach
in claudicant (pre-ABI, 0.59 6 0.16 vs 0.59 6 0.16;
P ¼ .65 and post-ABI, 0.90 6 0.17 vs 0.90 6 0.15;
P ¼ .81) and in CLI patients (pre-ABI, 0.46 6 0.26 vs
0.42 6 0.27; P ¼ .37 and post-ABI, 0.83 6 0.18 vs
0.84 6 0.18; P ¼ .82). The improvement of ABI in
each approach was obviously found in claudicant andCLI patients. However, the change of ABI was almost
similar in both groups.
After adjusting all end points for the baseline variables
of age, gender, previous smoker, COPD, lesion length,
reference vessel diameter and stent fracture, the subintimal
approach was found to be similar to the intraluminal
approach for primary patency (HR, 1.21; 95% CI, 0.94-
1.56; adjusted P ¼ .14), assisted-primary patency (HR,
0.85; 95% CI 0.61-1.18; adjusted P ¼ .33), and secondary
patency (HR, 0.89; 95% CI, 0.58-1.38; adjusted P ¼ .61).
There was also no signiﬁcant difference in overall survival
(HR, 0.94; 95% CI, 0.60-1.49; adjusted P ¼ .80) and
limb salvage rate (HR, 0.28; 95% CI, 0.06-1.23; adjusted
P ¼ .09) between the groups (Table IV). However, the
subintimal approach tended to be associated with better
results in CLI patients.
DISCUSSION
In this study, we examined intraluminal and subintimal
approaches for treatment of occluding lesions of 10 cm or
longer. In cases in which stent placement was required, the
rate of complications and the patency were similar with the
two approaches, but the procedural time was signiﬁcantly
longer for the intraluminal approach.
The intraluminal approach is widely used among the
participants in the current study for guidewire advance-
ment because many physicians performing EVT for the
lower extremities are endovascular practitioners and treat
A B C D
HGFE
Fig 3. Assisted-primary patency: A, Intention-to-treat (ITT) analysis; B, As-treated (AS) analysis. Secondary patency:
C, ITT analysis; D, AS analysis. Overall survival: E, ITT analysis; F, AS analysis. Limb salvage rate: G, ITT analysis;
H, AS analysis.
A B
Fig 4. Limb salvage rate in patients with critical limb ischemia (CLI). A, Intention-to-treat (ITT) analysis.
B, As-treated (AS) analysis.
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 6 Soga et al 1553occluding lesions using techniques similar to those used in
coronary intervention. In this study, in all but one of the
facilities, EVT was performed by interventional cardiolo-
gists, and an average of 72% (averages at individual facilitiesranging from 59% to 100%) selected an intraluminal
approach as the initial approach. Crossover to a subintimal
approach occurred in 0% to 100% of patients at different
facilities, showing a large difference between facilities.
Table IV. Hazard ratio (HR) of subintimal vs intraluminal approach
Outcome
Intraluminal
(n ¼ 651),
No. (%)
Subintimal
(n ¼ 251),
No. (%)
Unadjusted HR
(95% CI) P value
Adjusteda HR
(95% CI) P value
Primary end point
Primary patency 231 (35) 93 (37) 1.14 (0.89-1.45) .30 1.21 (0.94-1.56) .14
Secondary end points
Assisted primary patency 170 (26) 50 (20) 0.77 (0.56-1.06) .11 0.85 (0.61-1.18) .33
Secondary patency 95 (15) 29 (12) 0.83 (0.55-1.26) .37 0.89 (0.58-1.38) .61
Overall survival 80 of 530 (15) 23 of 189 (12) 0.87 (0.55-1.38) .55 0.94 (0.60-1.49) .80
Limb salvage in CLI 19 of 190 (10) 2 of 69 (3) 0.28 (0.07-1.19) .08 0.28 (0.06-1.23) .09
CI, Conﬁdence interval; CLI, critical limb ischemia; COPD, chronic obstructive pulmonary disease.
aAdjusted by covariates with signiﬁcant multivariate impact on investigated outcome measures: age, gender, previous smoker, COPD, lesion length, reference
vessel diameter, and stent fracture.
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nical results, but also on factors such as procedural time,
amount of contrast media, status of patients, and use of
the catheter room. Therefore, evaluation of crossover is
difﬁcult, but even interventional cardiologists proﬁcient in
the use of a guidewire changed from an intraluminal to
a subintimal approach in 25% of cases. This reﬂects the
difﬁculty of intraluminal angioplasty.
A bidirectional approach in which distal puncture is
additionally performed for cases with unsuccessful ante-
grade use of a guidewire is common among the participants
of this study, and there was no difference in the use of this
procedure between the intraluminal and subintimal groups.
Distal puncture is performed at comparatively high rates
because a re-entry device is not available in Japan, and
access to blood vessels is easy due to the small number of
obese patients. In addition, surgeons prefer addition of
distal puncture because a stent can be placed at the entry
and exit of the lesion without extending the lesion length
by advancing a guidewire from the distal true lumen to
the lesion.
EVT performed using the loop technique with
a 0.035-inch guidewire is considered to be subintimal
angioplasty because the guidewire is intentionally advanced
to the subintimal lumen; however, the guidewire may not
pass subintimally in all cases. In some cases, guidewires
dealing with subintimal approach may be crossing in part
intraluminal. In evaluation by IVUS in a small number of
subjects in this study, it was observed that the wire passed
through the true lumen in many cases and through the
subintimal lumen in a few others. Conversely, the intralu-
minal procedure was performed using a 0.014- or 0.018-
inch guidewire to ﬁnd the true lumen; however, this was
also not always successful. Thus, the preprocedural choice
of an intraluminal or subintimal approach was not always
consistent with the luminal site through which the wire
passed. The frequency of such inconsistency was unclear
and a study of the wire passage site using IVUS is required
to compare the subintimal and intraluminal approaches
more accurately. Thus, in this study, we compared the
“intraluminal vs subintimal approach,” rather than “intra-
luminal vs subintimal angioplasty.”Although the results of this study support the validity
of a subintimal approach, the advances in catheter devices
in recent years, as seen in The Crosser (Bard Peripheral
Vascular, Inc, Tempe, Ariz), now enable a wire to pass
selectively through the true lumen. As it becomes easier
to advance a guidewire to the true lumen, the importance
of the subintimal approach may be diminished. Dilation of
self-expandable stents placed in a true lumen might reduce
angiodynia accompanying outward force in the chronic
phase. Based on this, the intraluminal approach remains
important as an optional procedure. However, endovascu-
lar stent grafts such as Viabahn (W. L. Gore and Associates,
Inc, Flagstaff, Ariz) are appropriate for the subintimal
approach (because the graft is largely unaffected by the
running region of the guidewire) in terms of the prevention
of severe complication such as vessel rupture.12,13 If good
therapeutic results can be obtained in the chronic phase
and the method is used widely, it may become unnecessary
to consider differences in the approaches.
Regarding costs, more guidewires were used in the
intraluminal approach than in the subintimal approach
(2.9 6 0.7 vs 1.7 6 0.6; P < .0001) and the usage rates
of body surface echography (18% vs 8%; P < .0001) and
IVUS (37% vs 16%; P < .0001) were also higher. However,
the number of stents used, hospitalization period, inci-
dence of complications, and therapeutic results in the
chronic phase were similar. Based on these data, we esti-
mated the costs of both approaches, assuming that the
costs after completion of the procedure with the guidewire
are the same. Using a conversion rate of 1 US dollar (USD)
to 90 yen, the costs were estimated based on the Japanese
insurance reimbursement price. Using a 0.035-inch hydro-
philic guidewire priced at 33 USD, 0.014- or 0.018-inch
guidewire at 181 USD, 4F-support catheter at 32 USD,
microcatheter at 444 USD, use of body surface echography
at 61 USD, and use of IVUS at 1300 USD, the costs for
completion of the guidewire procedure in the intraluminal
and subintimal approaches were 1600 USD and 540 USD,
respectively. Therefore, medical costs may be reduced by
about 1000 USD per guidewire procedure using a subinti-
mal approach. In addition, the procedural time for the
intraluminal approach was longer (117 minutes vs 93
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costs. Furthermore, about 25% of patients in whom an
intraluminal approach was initially used underwent cross-
over to a subintimal approach. Therefore, comparatively
higher costs may be incurred with no real advantage in
immediate and 3-year results. We note that the costs for
a re-entry device were not included in the costs of the sub-
intimal approach because this device is not available in
Japan, and this issue may require further examination.
Limitations. There are several limitations in this study.
First, the study was performed as a retrospective analysis of
a large-scale prospective database. Therefore, a multicenter
randomized trial would be required to verify the ﬁndings.
There was also a chance of bias in many of the data
assignments. Second, crossover was observed in many
patients in the intraluminal group, and this might have
affected the end points. To compensate for this limitation,
we performed an AT analysis as well. Vessel patency was
evaluated by duplex ultrasound or angiography and not by
serial angiography, which could have changed the patency
rate. Finally, a ﬁrst-generation stent was used in this anal-
ysis, and use of a new generation stent or drug-eluting stent
might have affected the vessel patency. Despite these
limitations, our results provide clinically important infor-
mation regarding EVT for patients with long occlusive
femoropopliteal lesions.
CONCLUSIONS
The incidence of immediate complications and 3-year
patency were similar for intraluminal and subintimal
approaches in stent placement for a long femoropopliteal
occlusion. Given the longer procedure time and rate of
crossover using the intraluminal approach, we suggest
that a subintimal approach may be preferred in the treat-
ment of long femoropopliteal occlusions with stenting.
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